Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
For more information visit www.olink.com
Location: United States, Massachusetts, Watertown
Employees: 201-500
Founded date: 2004
Investors 2
| Date | Name | Website |
| - | Beijer Ven... | beijervent... |
| - | Summa Equi... | summaequit... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 23.04.2024 | Capitainer Recruits New Sales and Distribution Manager to St... | Capitainer Recruits New Sales and Distribution Manager to Strengthen the Sales Organization Tue, Apr... | news.cisio... |
| 08.03.2024 | Olink announces change of date for Annual General Meeting | - | globenewsw... |
| 07.03.2023 | NUS Medicine Implements Olink Technology To Accelerate Preci... | Olink Holding AB announced that the Yong Loo Lin School of Medicine, National University of Singapor... | aithority.... |
| 31.08.2021 | CellCarta expands its biomarker capabilities for clinical tr... | MONTRÉAL, Aug. 31, 2021 /PRNewswire/ -- CellCarta and Olink Proteomics AB announced today a strategi... | en.prnasia... |